Company Deltex Medical Group plc

Equities

DEMG

GB0059337583

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Chiffre d''affaires - Rate of surprise

Sector Medical Monitoring Systems

Market Closed - London S.E. Other stock markets 11:35:00 2024-04-26 am EDT			5-day change	1st Jan Change
0.135 ^GBX	0.00%		+8.00%	-6.90%

Mar. 28	Earnings Flash (DEMG.L) DELTEX MEDICAL GROUP Posts FY23 Revenue GBP1.8M	MT
Mar. 28	Earnings Flash (DEMG.L) DELTEX MEDICAL GROUP Posts FY23 Loss GBX-0.11	MT

Deltex Medical Group Plc is a United Kingdom-based medical device company. The Company develops, manufactures and distributes a hemodynamic monitoring technology. The Company's TrueVue platform offers three monitoring technologies, such as Oesophageal Doppler Monitoring (ODM+), Pulse Pressure Waveform Analysis (PPWA) and High Definition Impedance CardioGraphy (HD-ICG). Its ODM+ is a fluid management and cardiac output monitoring technology to directly measure both flow and pressure in adults and pediatrics. HD-ICG provides continuous and sensitive measurements of cardiac output and other hemodynamic parameters. The system is stabilized using HD-Z signal filter technology. HD-ICG disposable electrodes are placed on the neck and chest. PPWA uses the researched pulse pressure wave algorithm, which is available to derive hemodynamic parameters, calibrated from the Doppler. Its applications include surgery, acute kidney injury, enhanced recovery, paediatric, and COVID-19 critical care.

Number of employees: 37

GBP in Million	2022	Weight	2023	Weight	Delta
Probes 80.2 %	2	72.5 %	1	80.2 %	-20.83%
Monitors 14.5 %	1	21.6 %	0	14.5 %	-51.96%
Other 5.2 %	0	5.8 %	0	5.2 %	-35.86%

GBP in Million	2022	Weight	2023	Weight	Delta
United Kingdom 30.9 %	1	25.9 %	1	30.9 %	-14.49%
United States 19.5 %	1	25.6 %	0	19.5 %	-45.44%
France 16.0 %	0	19.6 %	0	16.0 %	-41.48%
Portugal 10.4 %	-	-	0	10.4 %	-
Other Countries 6.2 %	0	5.8 %	0	6.2 %	-23.61%
Latin America 6.0 %	0	12.2 %	0	6.0 %	-64.80%
Scandinavia 3.9 %	-	-	0	3.9 %	-
Hong Kong 3.8 %	0	1.9 %	0	3.8 %	+41.67%
South Korea 3.2 %	0	5.3 %	0	3.2 %	-57.58%

Managers	Title	Age	Since
Andrew Mears CEO	Chief Executive Officer	55	88-12-31
Natalie Wettler DFI	Director of Finance/CFO	-	21-05-26

Members of the board	Title	Age	Since
Nigel Keen CHM	Chairman	77	87-12-31
Christopher Jones BRD	Director/Board Member	-	15-05-31
Benjamin Edward Carswell BRD	Director/Board Member	50	Nov. 30
Andrew Mears CEO	Chief Executive Officer	55	88-12-31
Natalie Wettler DFI	Director of Finance/CFO	-	21-05-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,896,025,700	616,389,217 ( 32.51 %)	0	32.51 %

Name	Equities	%	Valuation
Nigel Keen 18.70 %	354,556,806	18.70 %	482 197 p
Herald Investment Management Ltd. 5.680 %	107,694,260	5.680 %	146 464 p
CriSeren Investments Ltd. 4.904 %	92,989,787	4.904 %	126 466 p
Mark Bradshaw 4.457 %	84,500,000	4.457 %	114 920 p
Michael Stubbs 2.505 %	47,500,000	2.505 %	64 600 p
Cantor Fitzgerald Europe 2.384 %	45,193,000	2.384 %	61 462 p
Charles Cazalet 1.811 %	34,335,789	1.811 %	46 697 p
Janus Henderson Investors UK Ltd. 1.712 %	32,466,516	1.712 %	44 154 p
Winterflood Securities Ltd (Market-Maker) 1.454 %	27,564,000	1.454 %	37 487 p
John Reilly 1.319 %	25,000,000	1.319 %	34 000 p

Deltex Medical Group Plc

Terminus Road

PO19 8TX, Chichester

+44 12 4377 4837

http://www.deltex.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Monitoring Systems

	1st Jan change	Capi.
DELTEX MEDICAL GROUP PLC	-6.90%	3.19M
IRHYTHM TECHNOLOGIES, INC.	+4.55%	3.48B
EKF DIAGNOSTICS HOLDINGS PLC	-12.80%	156M
MEDIANA CO.,LTD	-15.69%	81.85M
NEUROTECH INTERNATIONAL LIMITED	+30.43%	59.71M

Medical Monitoring Systems